ClinicalTrials.Veeva

Menu

Progesterone on the Day of Ovulation Induction is Associated With Pregnancy Outcome (ProgBBN)

B

Bollmann Bruckner Noss

Status

Completed

Conditions

Female Infertility

Study type

Observational

Funder types

Other

Identifiers

NCT01426152
Prog2006-2011
BBN (Other Identifier)

Details and patient eligibility

About

Progesterone levels measured in blood/serum of patients on the day of ovulation induction following controlled ovarian stimulation for in vitro fertilization may be associated with pregnancy outcome. The hypothesis is that higher progesterone levels are associated with lower implantation rates due to changes in the endometrial receptivity.

Enrollment

2,555 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • IVF/ICSI following controlled ovarian stimulation
  • progesterone measured on the day of ovulation induction
  • informed consent

Exclusion criteria

  • missing consent

Trial design

2,555 participants in 3 patient groups

Low level progesterone group (1)
Description:
Progesterone \< 1.50 ng/mL on day of ovulation induction
Medium level progesterone group (2)
Description:
Progesterone 1.51-1.99 ng/mL on the day of ovulation induction
High level progesterone group (3)
Description:
Progesterone \> 1.99 ng/mL on the day of ovulation induction

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems